DK0739205T3 - Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner - Google Patents

Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner

Info

Publication number
DK0739205T3
DK0739205T3 DK95905416T DK95905416T DK0739205T3 DK 0739205 T3 DK0739205 T3 DK 0739205T3 DK 95905416 T DK95905416 T DK 95905416T DK 95905416 T DK95905416 T DK 95905416T DK 0739205 T3 DK0739205 T3 DK 0739205T3
Authority
DK
Denmark
Prior art keywords
glucitol
imino
hepatitis
treatment
pct
Prior art date
Application number
DK95905416T
Other languages
English (en)
Inventor
Timothy M Block
Baruch S Blumberg
Raymond A Dwek
Original Assignee
Searle & Co
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co, Monsanto Co filed Critical Searle & Co
Application granted granted Critical
Publication of DK0739205T3 publication Critical patent/DK0739205T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95905416T 1994-01-13 1994-12-23 Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner DK0739205T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18151994A 1994-01-13 1994-01-13
PCT/US1994/014548 WO1995019172A1 (en) 1994-01-13 1994-12-23 Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections

Publications (1)

Publication Number Publication Date
DK0739205T3 true DK0739205T3 (da) 2000-05-01

Family

ID=22664619

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95905416T DK0739205T3 (da) 1994-01-13 1994-12-23 Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner

Country Status (14)

Country Link
US (1) US6037351A (da)
EP (1) EP0739205B1 (da)
JP (1) JP3628021B2 (da)
KR (1) KR100348657B1 (da)
CN (1) CN1074921C (da)
AT (1) ATE186836T1 (da)
AU (1) AU1403795A (da)
CA (1) CA2181033C (da)
DE (1) DE69421828T2 (da)
DK (1) DK0739205T3 (da)
ES (1) ES2140652T3 (da)
GR (1) GR3032527T3 (da)
PT (1) PT739205E (da)
WO (1) WO1995019172A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100532A1 (en) * 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
MY122499A (en) 1997-11-10 2006-04-29 Searle & Co Use of alkylated iminosugars to treat multidrug resistance
ATE331515T1 (de) * 1998-02-12 2006-07-15 Searle Llc Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen
EP1714676A3 (en) * 1998-02-12 2006-11-15 G.D. Searle LLC. Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
EP1173161A2 (en) 1999-02-12 2002-01-23 G.D. SEARLE & CO. Glucamine compounds for treating hepatitis virus infections
EP1658846B1 (en) * 1999-02-12 2008-07-30 United Therapeutics Corporation N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol for treating hepatitis virus infections
EP1165080A2 (en) * 1999-02-12 2002-01-02 G.D. SEARLE & CO. Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
EP1210082B1 (en) 1999-08-10 2008-01-02 The Chancellor, Masters And Scholars Of The University Of Oxford Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions
EP1261339A1 (en) * 2000-02-14 2002-12-04 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
JP2008509902A (ja) * 2004-08-13 2008-04-03 ミジェニックス インコーポレイテッド Ｈｅｐａｄｎａｖｉｒｉｄａｅ感染を処置または防止するための組成物および方法
CA2652958C (en) 2006-05-24 2015-11-17 United Therapeutics Corporation Deoxynojirimycin and d-arabinitol analogs and methods of using
EP2054076A2 (en) * 2006-08-21 2009-05-06 United Therapeutics Corporation Combination therapy for treatment of viral infections
US8097728B2 (en) 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
JP2013233113A (ja) * 2012-05-09 2013-11-21 Osaka Univ 物理的負荷への耐性が向上した細胞の製造方法
RU2743694C1 (ru) * 2019-12-04 2021-02-24 Общество с ограниченной ответственностью "29 февраля" Миглустат N-бутил-1,5-дидезокси-1,5-имино-D-глюцит

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus
US4957926A (en) * 1988-12-22 1990-09-18 Monsanto Company Method of treating herpesviruses
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement

Also Published As

Publication number Publication date
EP0739205A1 (en) 1996-10-30
JPH09508111A (ja) 1997-08-19
CN1074921C (zh) 2001-11-21
AU1403795A (en) 1995-08-01
CA2181033A1 (en) 1995-07-20
WO1995019172A1 (en) 1995-07-20
DE69421828T2 (de) 2000-04-20
ATE186836T1 (de) 1999-12-15
PT739205E (pt) 2000-04-28
KR100348657B1 (ko) 2003-08-02
ES2140652T3 (es) 2000-03-01
CA2181033C (en) 2007-09-04
DE69421828D1 (de) 1999-12-30
EP0739205B1 (en) 1999-11-24
GR3032527T3 (en) 2000-05-31
US6037351A (en) 2000-03-14
CN1149253A (zh) 1997-05-07
JP3628021B2 (ja) 2005-03-09

Similar Documents

Publication Publication Date Title
DK0739205T3 (da) Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner
NO20073151L (no) Fremgangsmater og sammensetninger for a behandle hepatitt C virus
BR0110023A (pt) Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite
DE60105424D1 (de) Methoden zur behandlung von delta hepatitis virus infektionen mit beta-l-2' deoxy-nucleosiden
HUT61296A (en) Process for producing substituted diaromatic compounds against aids and pharmaceutical compositions comprising same
UA41315C2 (uk) Вакцинна композиція проти респіраторно-синцитіального вірусу, спосіб стимулювання імунної системи індивідуума для індукції захисту проти респіраторно-синцитіального вірусу
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides.
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
AU3216695A (en) Lipid analogs for treating viral infections
ZA956986B (en) Methods of inhibiting viral replication.
FR2741619B1 (fr) Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
BR9502085A (pt) Derivado de 11,21-bis-fenil-19-norpregnano,processo de preparação do mesmo e composição farmaceutica
DK0915894T3 (da) Nukleotidanaloger
NZ217398A (en) Angiotensin-converting enzyme(ace)inhibitor and pharmaceutical composition
ATE339211T1 (de) L-fmau zur behandlung von hepatitis-delta-virus- infizierung
EP0594795A4 (en) MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT.
MD940152A (ro) Compoziţie farmaceutică pentru tratarea infecţiilor şi bolilor, provocate de virusul hepatitei V (HBV)
KR960702456A (ko) 4-(p-플로오로페닐)-3-[(3,4-(메틸렌디옥시)페녹시)메틸]피페리딘의 n-p-할로벤조일메틸 유도체(n-p-halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]piperidine)
SE8302452D0 (sv) Method for treatment of senile dementia
FR2729665B1 (fr) Nouveaux derives de glycylanilides, leur preparation et leur application en therapeutique
DE69610851D1 (de) Disubstituierte piperidine-derivate
WO1996013263A3 (en) Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis
FI944076A (fi) Menetelmä terapeuttisesti käytt¦kelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
GR930100335A (el) Ενώσεις και μέ?οδοι αναστολής του ΗΙV και των σχετικών ιών.